AR084885A2 - Implante para implantacion subcutanea en un animal - Google Patents

Implante para implantacion subcutanea en un animal

Info

Publication number
AR084885A2
AR084885A2 ARP120100165A ARP120100165A AR084885A2 AR 084885 A2 AR084885 A2 AR 084885A2 AR P120100165 A ARP120100165 A AR P120100165A AR P120100165 A ARP120100165 A AR P120100165A AR 084885 A2 AR084885 A2 AR 084885A2
Authority
AR
Argentina
Prior art keywords
implant
parasiticidal
agent
dose
pellet
Prior art date
Application number
ARP120100165A
Other languages
English (en)
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of AR084885A2 publication Critical patent/AR084885A2/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0069—Devices for implanting pellets, e.g. markers or solid medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Medical Informatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Anesthesiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)

Abstract

Reivindicación 1: Un implante para implantación subcutánea en un animal que comprende un agente parasiticida, caracterizado porque dicho implante incluye una pluralidad de pellets (14, 16), en donde por lo menos un pellet comprende una dosis de agente parasiticida formulado para liberación inmediata, y por lo menos otro pellet comprende una dosis de agente parasiticida formulado para liberación prolongada.Reivindicación 4: Un implante de acuerdo con cualquiera de las reivindicaciones precedentes, caracterizado porque el agente parasiticida es una avermectina, milbemicina, milbemicina oxima, fenbendazol, lufenuron o derivados o mezclas de los mismos. Reivindicación 5: Un implante de acuerdo con la reivindicación 4, caracterizado porque la avermectina es ivermectina, doramectina, moxidectina, eprinomectrina, abamectina o derivados o mezclas de las mismas. Reivindicación 7: Un implante de acuerdo con cualquiera de las reivindicaciones precedentes, caracterizado porque cada pellet que comprende un dosis de agente parasiticida de liberación inmediata comprende además un agente de desintegración y cada pellet que comprende una dosis de pellet de agente parasiticida de liberación prolongada comprende además un agente aglutinante.
ARP120100165A 1998-09-30 2012-01-18 Implante para implantacion subcutanea en un animal AR084885A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/163,646 US6645192B2 (en) 1998-09-30 1998-09-30 Pellet implant system for immediate and delayed release of antiparasitic drug

Publications (1)

Publication Number Publication Date
AR084885A2 true AR084885A2 (es) 2013-07-10

Family

ID=22590937

Family Applications (2)

Application Number Title Priority Date Filing Date
ARP990104912A AR018691A1 (es) 1998-09-30 1999-09-29 Disposicion de implante de pellets para la liberacion inmediata y retardada de drogas antiparasitarias
ARP120100165A AR084885A2 (es) 1998-09-30 2012-01-18 Implante para implantacion subcutanea en un animal

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ARP990104912A AR018691A1 (es) 1998-09-30 1999-09-29 Disposicion de implante de pellets para la liberacion inmediata y retardada de drogas antiparasitarias

Country Status (9)

Country Link
US (2) US6645192B2 (es)
EP (1) EP0990450B1 (es)
AR (2) AR018691A1 (es)
AT (1) ATE309838T1 (es)
AU (1) AU763614B2 (es)
BR (1) BR9904379A (es)
CA (1) CA2283054C (es)
DE (1) DE69928344D1 (es)
ZA (1) ZA996060B (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6648849B2 (en) 2001-06-27 2003-11-18 Ethicon, Inc. Medicinal implant and device and method for loading and delivering implants containing drugs and cells
AUPR602401A0 (en) * 2001-06-29 2001-07-26 Smart Drug Systems Inc Sustained release delivery system
AUPR602501A0 (en) * 2001-06-29 2001-07-26 Smart Drug Systems Inc Sustained release pharmaceutical composition
AUPR610501A0 (en) * 2001-07-04 2001-07-26 Smart Drug Systems Inc Treatment of parasitic disease
AU2005232685A1 (en) * 2004-04-07 2005-10-27 Intervet International B.V. Efficacious composition of a benzimidazole, an avermectin and praziquantel and related methods of use
US8150543B2 (en) 2007-09-28 2012-04-03 Siemens Aktiengesellschaft Methods, apparatus and articles for an air jet loom
US9717896B2 (en) 2007-12-18 2017-08-01 Gearbox, Llc Treatment indications informed by a priori implant information
US8636670B2 (en) 2008-05-13 2014-01-28 The Invention Science Fund I, Llc Circulatory monitoring systems and methods
US20090287120A1 (en) 2007-12-18 2009-11-19 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Circulatory monitoring systems and methods
US9572615B2 (en) 2012-07-18 2017-02-21 Jmea Corporation Detachable front delivery assembly for a tissue repair system
EP3302354B1 (en) 2015-06-03 2023-10-04 i2o Therapeutics, Inc. Implant placement systems
USD851755S1 (en) * 2015-10-22 2019-06-18 Eyepoint Pharmaceuticals Us, Inc. Ocular inserter
USD840030S1 (en) 2016-06-02 2019-02-05 Intarcia Therapeutics, Inc. Implant placement guide
USD860451S1 (en) 2016-06-02 2019-09-17 Intarcia Therapeutics, Inc. Implant removal tool
BR112020011506A2 (pt) 2017-12-12 2020-11-17 Intervet International B.V. composições farmacêuticas de isoxazolina implantáveis e usos das mesmas
USD933219S1 (en) 2018-07-13 2021-10-12 Intarcia Therapeutics, Inc. Implant removal tool and assembly
CN109568282A (zh) * 2018-12-28 2019-04-05 河北威远动物药业有限公司 一种含乙酰氨基阿维菌素的瘤胃缓释片剂及制备方法

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4799921A (en) * 1984-08-20 1989-01-24 Johnson Ronald F Method for implanting retainers and implants in cattle
US5098425A (en) 1985-08-16 1992-03-24 Alza Corporation Method of administering a ruminant dispensing device comprising density member dispersed in hydrogel member
US4994227A (en) 1986-03-10 1991-02-19 American Cyanamid Company Method for the preparation of sustained released bolus formulation
US5200196A (en) 1986-05-09 1993-04-06 Alza Corporation Improvement in pulsed drug therapy
US4664227A (en) * 1986-08-29 1987-05-12 Hansen Orville S Portable balustrade and platform assembly
US4892778A (en) * 1987-05-27 1990-01-09 Alza Corporation Juxtaposed laminated arrangement
US5035891A (en) 1987-10-05 1991-07-30 Syntex (U.S.A.) Inc. Controlled release subcutaneous implant
US4847243A (en) 1987-10-08 1989-07-11 Merck & Co., Inc. Treatment for fescue toxicosis in grazing animals
US5633002A (en) * 1988-10-04 1997-05-27 Boehringer Ingelheim Gmbh Implantable, biodegradable system for releasing active substance
US5202128A (en) 1989-01-06 1993-04-13 F. H. Faulding & Co. Limited Sustained release pharmaceutical composition
IE904098A1 (en) * 1989-11-13 1991-05-22 Nova Pharm Corp Lipospheres for controlled delivery of substances
DE4019617A1 (de) * 1990-06-20 1992-01-02 Thera Ges Fuer Patente Implantierbares wirkstoffdepotmaterial
US5417682A (en) * 1991-01-30 1995-05-23 Alza Corporation Device for administering active agent to biological environment
US5204116A (en) 1991-05-01 1993-04-20 Alza Corporation Dosage form providing immediate therapy followed by prolonged therapy
AU652984B2 (en) * 1992-01-14 1994-09-15 Endo Pharmaceuticals Solutions Inc. Preparation of homogeneous hydrogel copolymers
US5609884A (en) 1992-08-31 1997-03-11 G. D. Searle & Co. Controlled release naproxen sodium plus naproxen combination tablet
US5759551A (en) * 1993-04-27 1998-06-02 United Biomedical, Inc. Immunogenic LHRH peptide constructs and synthetic universal immune stimulators for vaccines
US5525621A (en) * 1994-05-20 1996-06-11 Cytos Pharmaceuticals Llc Imidazole derivatives as protective agents in reperfusion injury and severe inflammatory responses
US5522797A (en) * 1995-01-03 1996-06-04 Ivy Laboratories, Inc. Slide action veterinary implanter
DE69612088T2 (de) 1995-02-24 2001-08-30 Novartis Ag Zusammensetzung zur bekämpfung von parasiten
US5840332A (en) * 1996-01-18 1998-11-24 Perio Products Ltd. Gastrointestinal drug delivery system
US5874418A (en) * 1997-05-05 1999-02-23 Cydex, Inc. Sulfoalkyl ether cyclodextrin based solid pharmaceutical formulations and their use
US5874098A (en) * 1997-05-28 1999-02-23 Ivy Laboratories, Inc. Pellet implant system
AU9742298A (en) 1997-09-23 1999-04-12 Pfizer Inc. Parasiticidal formulations
US5891845A (en) * 1997-11-21 1999-04-06 Fuisz Technologies Ltd. Drug delivery systems utilizing liquid crystal structures
AUPP279698A0 (en) 1998-04-03 1998-04-30 Sunscape Developments Limited Sustained release formulation

Also Published As

Publication number Publication date
US6645192B2 (en) 2003-11-11
EP0990450A2 (en) 2000-04-05
ATE309838T1 (de) 2005-12-15
CA2283054A1 (en) 2000-03-30
US20010049489A1 (en) 2001-12-06
EP0990450A3 (en) 2000-08-02
AU763614B2 (en) 2003-07-31
EP0990450B1 (en) 2005-11-16
CA2283054C (en) 2009-12-15
BR9904379A (pt) 2000-09-05
AU4873799A (en) 2000-04-06
US20040047888A1 (en) 2004-03-11
ZA996060B (en) 2000-04-04
DE69928344D1 (de) 2005-12-22
AR018691A1 (es) 2001-11-28

Similar Documents

Publication Publication Date Title
AR084885A2 (es) Implante para implantacion subcutanea en un animal
PE20011289A1 (es) Composiciones antihelminticas que comprenden lactonas macrociclicas y espirodioxepinoindoles
AR010375A1 (es) Composiciones endo-ectoparasiticidas
ES2114471B1 (es) Nuevos compuestos de paroxetina y procedimiento para su preparacion.
CY1110376T1 (el) Χρηση μιας συνθεσης που περιλαμβανει φορμοτερολη και βουδεσονιδη για την προληψη απο ή τη θεραπευτικη αντιμετωπιση μιας οξειας καταστασης ασθματος
AR027091A1 (es) Forma de dosificacion de farmacos accionada por un hidrogel
BRPI9809791B8 (pt) compostos imuno efetores de fosfato de aminoalquil glucosamina e composições compreendendo os mesmos
ES2146300T3 (es) Utilizacion de composiciones antihelminticas para el tratamiento de infecciones causadas por anoplocephala perfoliata en equidos.
ES2193406T3 (es) Composiciones y metodos para mejorar la funcion intestinal.
ES2187822T3 (es) Comprimidos de disgregacion rapida.
BRPI0017535B8 (pt) composto de difenil-uréias substituídas com ômega-carbóxi-arilas
DE69824277D1 (de) Stabile medizinische zusammenstellungen die 4,5-epoxymorphinanderivate enthalten
BR0201290A (pt) Bola para jogo de basquete e método de construir a mesma
BRPI0408655A (pt) formulações compreendendo um agente ativo e cacau em pó e a sua utilização
BRPI0313148B8 (pt) formulações sólidas matriciais de lamotrigina contendo revestimento externo e perfuração em tal revestimento
ZA961467B (en) Composition for controlling parasites
AR043070A1 (es) Sistema monolitico que contiene una o mas drogas, formado por tres capas con diferentes mecanismos de liberacion
DK1171101T3 (da) Fremgangsmåde til fremstilling af en vanduoplöselig amorf depotmatrix
HU213677B (en) Pharmaceutical compositions for preventing and treating tumor diseases, and process for producing them
CA2314286A1 (en) Anthelmintic compositions
PT1150686E (pt) Matriz directamente compressivel para libertacao controlada de doses diarias unitarias de claritromicina
GT199800149A (es) Formulaciones parasiticidas.
ES2033819T3 (es) Un procedimiento para preparar compuestos para uso en terapia.
DE60316714D1 (de) Pharmazeutische formulierung enthaltend olanzapin
AR047480A1 (es) Composicion para la prevencion y/o tratamiento de enfermedades metabolicas oseas; proceso de preparacion y uso de esta composicion

Legal Events

Date Code Title Description
FB Suspension of granting procedure